Skip to Main Content

finance

Here you will find multiple articles on the financing of health care. Topics include the role of insurance companies, the impact of government regulation on the health care system and the latest trends in health care financing, such as the rise of value-based care and the use of health savings accounts.

Latest

Insurance Bob Herman

STAT Plus: UnitedHealth’s profit jumps as medical costs come in lower than expected

The Readout Damian Garde

STAT Plus: Cell and gene therapies could be a safer bet than other drugs

Biotech Allison DeAngelis

STAT Plus: Life sciences deals on track to hit lowest point since 2017

The Readout Damian Garde

STAT Plus: With Ozempic, Wall Street moves on from a whole other class of medicines

Health Care Inc. Bob Herman

What’s next in the Kaiser Permanente strike

Hospitals Tara Bannow

STAT Plus: Dana-Farber CEO on Mass General split: Boston needed a dedicated cancer hospital

The Readout Meghana Keshavan

STAT Plus: Want a biotech buyout? Target cancer

Biotech Andrew Joseph

STAT Plus: Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy

All Coverage

Exclusive Jonathan Wosen

STAT Plus: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise

Insurance Tara Bannow

STAT Plus: Elevance’s embattled bid to buy Louisiana’s Blues plan was a stretch to begin with

advertisement

Hospitals Tara Bannow

STAT Plus: CommonSpirit’s answer to losing money: get bigger

Hospitals Tara Bannow

STAT Plus: Patients, doctors press FTC to beef up hospital merger scrutiny

Hospitals Brittany Trang

STAT Plus: Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale?

Hospitals Tara Bannow

STAT Plus: Experts fear private equity will pour gas on cardiology’s overuse problem

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year

Health Tech Mario Aguilar

STAT Plus: Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Biotech Allison DeAngelis

STAT Plus: Former Pear Therapeutics executives start new VC firm, with biotech veteran Bob Langer as adviser

Special Report Bob Herman, J. Emory Parker, Adam Feuerstein, Lizzy Lawrence and Mohana Ravindranath

STAT Plus: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows

Insurance Bob Herman

STAT Plus: After Optum Health’s lowest profit margin in a decade, UnitedHealth makes changes

Hospitals Tara Bannow

STAT Plus: Hospitals are dialing back on venture capital investing

Insurance Tara Bannow

STAT Plus: With new acquisitions, Humana and CVS hope to turn members into patients

Health Tech Mario Aguilar

STAT Plus: With profitability in sight, Talkspace is budding into a digital health success story

Hospitals Tara Bannow

STAT Plus: HCA says smaller share of spending going to labor

Biotech Allison DeAngelis

STAT Plus: VC firm starts a new synthetic biology incubator, headed by a former Broad Institute scientist

Hospitals Tara Bannow

STAT Plus: UHS finance chief said company favors patients whose insurance pays more

Politics Rachel Cohrs

STAT Plus: Democrats decry a new health package as too easy on private equity

Health Tech Lizzy Lawrence

STAT Plus: Medical device maker Teleflex to acquire urology company Palette Life Sciences for $600 million

Hospitals Tara Bannow

STAT Plus: Extensive review finds private equity owners jack up the cost of medical care

Hospitals Bob Herman

STAT Plus: States increasingly look to regulate hospital facility fees